PRESIDENT’S EDITORIAL

First of all, I want to thank our existing customers who renew their trust in us every day and the new customers who join us in this special industry.
In 2020, the health crisis due to COVID-19 has impacted the global organization and international needs for pharmaceuticals. Cenexi has been keen and successful in maintaining close relationships with its customers during this period to be more than ever a trusted partner.
2021 promises to be unprecedented for Cenexi. Our Group is moving and transforming. Appointed Chairman in July 2020, I launched an ambitious dynamic of change and modernization of the Group, while continuing our efforts.
We will focus on strengthening our industrial excellence which has made us a key group in the sterile sector.
We will develop our service offering in development and industrial transfer to cover all of your needs, from A to Z.
We will strengthen the synergies between our sites to relieve your industrial problems.
2021 is the year of a new collaboration,
Happy New Year to you and your loved ones

Christophe DURAND
President

INNOVATOR IN STERILE INJECTABLES

With over a decade serving the global pharmaceutical market, and now four manufacturing sites with excellent regulatory records, Cenexi is a contract development and manufacturing organization (CDMO) that has rapidly built a strong reputation for its sterile fill-finish expertise, innovation and quality. Cenexi is sharply focused on surpassing customer expectations with flexible capacity, deep technical and regulatory expertise, formulation development, and exceptional customer service surrounding capability for pre-filled syringes, ampoules and vials.

Learn more.

CENEXI SERVICES

Our Cenexi Services division offers exceptional regulatory, formulation and analytical expertise, with a team that will manage your entire project from pre-formulation and formulation to pilot scale and commercial production – for all dosage forms. Cenexi’s four state-of-the-art manufacturing facilities are located in France and Belgium, and all sites have been successfully inspected and approved by the major regulatory bodies, including the FDA (USA), EMA (EU), ANSM (France), PMDA (Japan), and KFDA (South Korea).

Learn more.

WHY CENEXI

Cenexi is a global provider of contract development and manufacturing services. We offer large, mid-size and small pharmaceutical and biotechnology customers a comprehensive breadth of drug product outsourcing services with a long facility record of compliance and reliable delivery, and deep scientific expertise within our team.

We are a leader in sterile product manufacturing, specializing in prefilled syringes, vials and ampoules, including high containment capacity for highly potent compounds. Our dosage form capabilities also extend to tablets and capsules, liquid oral dose, suppositories and creams. With our flexible, customer-oriented approach, we look to build relationships capable of serving many of your drug product manufacturing projects.

Strong regulatory, technical and scientific expertise helps us to establish a clear understanding of project objectives and provide exceptional management of complex product portfolios or technical transfers for customers worldwide.

Learn more.

LET’S TALK

If you are interested in finding out more about a CDMO that offers world-class, flexible capacity for multiple dosage forms and is motivated to work with you at every stage of development and manufacturing, contact Cenexi. We look forward to discussing how we can serve you.

Let’s talk !
or call +33 1 43 94 88 00

 

Interested in joining Cenexi Group?

Learn more about our job openings here